| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 ATP8A2 ATP10B CHD1 DNAH14 LONP1 RAD54B KIF14 ATP13A3 DNAH8 IPO8 DYNC2H1 DDX60 ATP6V1E2 ZNFX1 MSH2 ATP10D MYH15 ATP5F1A XRCC6 | 1.52e-05 | 614 | 219 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH7 ATP8A2 LRRK2 ATP10B CHD1 LONP1 RAB33A RAB30 SEPTIN14 KIF14 ATP13A3 DNM1P34 DNAH8 DYNC2H1 DDX60 MSH2 ATP10D RAB41 RHEBL1 ATP5F1A XRCC6 | 1.32e-04 | 775 | 219 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH7 ATP8A2 LRRK2 ATP10B CHD1 LONP1 RAB33A RAB30 SEPTIN14 KIF14 ENPP5 ATP13A3 DNM1P34 DNAH8 DYNC2H1 DDX60 MSH2 ATP10D RAB41 RHEBL1 ATP5F1A XRCC6 | 1.45e-04 | 839 | 219 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.48e-04 | 10 | 219 | 3 | GO:0019531 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH7 ATP8A2 LRRK2 ATP10B CHD1 LONP1 RAB33A RAB30 SEPTIN14 KIF14 ENPP5 ATP13A3 DNM1P34 DNAH8 DYNC2H1 DDX60 MSH2 ATP10D RAB41 RHEBL1 ATP5F1A XRCC6 | 1.48e-04 | 840 | 219 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH7 ATP8A2 LRRK2 ATP10B CHD1 LONP1 RAB33A RAB30 SEPTIN14 KIF14 ENPP5 ATP13A3 DNM1P34 DNAH8 DYNC2H1 DDX60 MSH2 ATP10D RAB41 RHEBL1 ATP5F1A XRCC6 | 1.48e-04 | 840 | 219 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.01e-04 | 11 | 219 | 3 | GO:0008271 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG CDHR3 OBSCN CKAP5 ITGAV ESYT2 DLG1 FN1 DSC2 DSG2 RTN4 DBNL NIBAN2 EGFR TENM1 CDH15 CDH18 | 3.45e-04 | 599 | 219 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 3.57e-04 | 3 | 219 | 2 | GO:0140351 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 ATP8A2 ATP10B CHD1 LONP1 KIF14 ATP13A3 DNAH8 DYNC2H1 DDX60 MSH2 ATP10D ATP5F1A XRCC6 | 3.85e-04 | 441 | 219 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 6.56e-04 | 16 | 219 | 3 | GO:0015116 | |
| GeneOntologyMolecularFunction | flippase activity | 7.90e-04 | 17 | 219 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | CHD1 GGT5 RAD54B XRN1 TARBP1 DNMT1 REV1 DDX60 NOB1 THUMPD3 POLR1C ZNFX1 MSH2 GGT2P ERVK-8 EXO1 XRCC6 | 7.93e-04 | 645 | 219 | 17 | GO:0140640 |
| GeneOntologyMolecularFunction | transporter activity | ATP8A2 TRPC1 PKD1L1 SLC28A3 ATP10B ITGAV SLC30A4 GGA3 SCN1A SCN5A ATP13A3 SLC26A3 IPO8 SLC6A16 SLC26A2 ATP6V1E2 SLC26A5 APOB GSDMC ATP10D SLC15A1 SLC17A1 GSDMD SFXN3 LRP2 CACNG4 ATP5F1A | 9.32e-04 | 1289 | 219 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.40e-04 | 18 | 219 | 3 | GO:0008569 | |
| GeneOntologyCellularComponent | intercalated disc | 8.27e-05 | 68 | 221 | 6 | GO:0014704 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 9.95e-05 | 101 | 221 | 7 | GO:0045334 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.74e-04 | 147 | 221 | 8 | GO:0030665 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.91e-04 | 79 | 221 | 6 | GO:0030669 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SNF8 TRAF3 SNX20 ATP8A2 LRRK2 SIGLEC5 ATP10B ITGAV SLC30A4 GGA3 AP2B1 AP1G1 WASHC5 VPS13A ELAPOR1 SYT1 DLG1 ATP13A3 ARHGAP21 STON1 DBNL SIGLEC14 APOB EGFR LRP2 CACNG4 PCDH7 UEVLD | 2.96e-04 | 1307 | 221 | 28 | GO:0030659 |
| GeneOntologyCellularComponent | cell surface | EPHB2 TNFRSF11A ITGAV PTGFRN RGMA PXDN UMODL1 LRFN5 SCN5A PKHD1 C3 FGF10 RC3H2 GFRAL DSG2 FOLH1 APOH LIFR HHLA2 EGFR LRP2 ROBO2 ROS1 CACNG4 ATP5F1A | 3.09e-04 | 1111 | 221 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | vesicle membrane | SNF8 TRAF3 SNX20 ATP8A2 LRRK2 SIGLEC5 ATP10B ITGAV SLC30A4 GGA3 AP2B1 AP1G1 WASHC5 VPS13A ELAPOR1 SYT1 DLG1 ATP13A3 ARHGAP21 STON1 DBNL SIGLEC14 APOB EGFR LRP2 CACNG4 PCDH7 UEVLD | 3.68e-04 | 1325 | 221 | 28 | GO:0012506 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 3.89e-04 | 14 | 221 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.90e-04 | 94 | 221 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 9.79e-04 | 237 | 221 | 9 | GO:0030136 | |
| Domain | fn3 | EPHB2 PRTG OBSCN PHYHIP NCAM2 UMODL1 MYBPHL TRIM36 FN1 LIFR ROBO2 ROS1 | 4.57e-07 | 162 | 218 | 12 | PF00041 |
| Domain | FN3 | EPHB2 PRTG OBSCN PHYHIP NCAM2 UMODL1 LRFN5 MYBPHL TRIM36 FN1 LIFR ROBO2 ROS1 | 6.39e-07 | 199 | 218 | 13 | PS50853 |
| Domain | FN3_dom | EPHB2 PRTG OBSCN PHYHIP NCAM2 UMODL1 LRFN5 MYBPHL TRIM36 FN1 LIFR ROBO2 ROS1 | 1.11e-06 | 209 | 218 | 13 | IPR003961 |
| Domain | Cse1 | 1.57e-06 | 3 | 218 | 3 | PF08506 | |
| Domain | Cse1 | 1.57e-06 | 3 | 218 | 3 | IPR013713 | |
| Domain | FN3 | EPHB2 PRTG OBSCN PHYHIP NCAM2 UMODL1 MYBPHL TRIM36 FN1 LIFR ROBO2 ROS1 | 1.87e-06 | 185 | 218 | 12 | SM00060 |
| Domain | Neural_cell_adh | 6.22e-06 | 4 | 218 | 3 | IPR009138 | |
| Domain | - | EPHB2 PRTG FSTL5 OBSCN PHYHIP SIGLEC5 NCAM2 PTGFRN PXDN UMODL1 LRFN5 PKHD1 MYBPHL TRIM36 MPZ FN1 SIGLEC14 LIFR HHLA2 HMCN1 ROBO2 ROS1 | 1.09e-05 | 663 | 218 | 22 | 2.60.40.10 |
| Domain | ARM-type_fold | NEK10 LRRK2 CKAP5 AP2B1 AP1G1 XPO6 NCAPD2 MMS19 TARBP1 IPO8 IPO7 ZNFX1 APOB CSE1L LTA4H | 1.13e-05 | 339 | 218 | 15 | IPR016024 |
| Domain | IMPORTIN_B_NT | 1.65e-05 | 14 | 218 | 4 | PS50166 | |
| Domain | ARM-like | NEK10 LRRK2 CKAP5 AP2B1 AP1G1 XPO6 NCAPD2 MMS19 TARBP1 IPO8 IPO7 KATNBL1 CSE1L | 1.82e-05 | 270 | 218 | 13 | IPR011989 |
| Domain | IBN_N | 2.23e-05 | 15 | 218 | 4 | PF03810 | |
| Domain | IGv | 2.71e-05 | 75 | 218 | 7 | SM00406 | |
| Domain | Ig-like_fold | EPHB2 PRTG FSTL5 OBSCN PHYHIP SIGLEC5 NCAM2 PTGFRN PXDN UMODL1 LRFN5 PKHD1 MYBPHL TRIM36 MPZ FN1 SIGLEC14 LIFR HHLA2 HMCN1 ROBO2 ROS1 | 2.87e-05 | 706 | 218 | 22 | IPR013783 |
| Domain | IBN_N | 2.94e-05 | 16 | 218 | 4 | SM00913 | |
| Domain | Importin-beta_N | 3.81e-05 | 17 | 218 | 4 | IPR001494 | |
| Domain | S04_transporter_CS | 5.30e-05 | 7 | 218 | 3 | IPR018045 | |
| Domain | - | NEK10 LRRK2 CKAP5 AP2B1 AP1G1 XPO6 NCAPD2 MMS19 IPO8 IPO7 CSE1L | 6.23e-05 | 222 | 218 | 11 | 1.25.10.10 |
| Domain | Ig_I-set | PRTG FSTL5 OBSCN NCAM2 PXDN LRFN5 MYBPHL SIGLEC14 HMCN1 ROBO2 | 8.17e-05 | 190 | 218 | 10 | IPR013098 |
| Domain | I-set | PRTG FSTL5 OBSCN NCAM2 PXDN LRFN5 MYBPHL SIGLEC14 HMCN1 ROBO2 | 8.17e-05 | 190 | 218 | 10 | PF07679 |
| Domain | IGc2 | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PXDN LRFN5 MYBPHL SIGLEC14 HMCN1 ROBO2 | 1.04e-04 | 235 | 218 | 11 | SM00408 |
| Domain | Ig_sub2 | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PXDN LRFN5 MYBPHL SIGLEC14 HMCN1 ROBO2 | 1.04e-04 | 235 | 218 | 11 | IPR003598 |
| Domain | Alpha_adaptinC2 | 1.25e-04 | 9 | 218 | 3 | PF02883 | |
| Domain | Alpha_adaptinC2 | 1.25e-04 | 9 | 218 | 3 | SM00809 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.25e-04 | 9 | 218 | 3 | IPR008152 | |
| Domain | SLC26A | 1.77e-04 | 10 | 218 | 3 | PS01130 | |
| Domain | Cadherin_C | 1.88e-04 | 25 | 218 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.88e-04 | 25 | 218 | 4 | IPR000233 | |
| Domain | SLC26A/SulP_fam | 2.42e-04 | 11 | 218 | 3 | IPR001902 | |
| Domain | STAS_dom | 2.42e-04 | 11 | 218 | 3 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.42e-04 | 11 | 218 | 3 | IPR011547 | |
| Domain | STAS | 2.42e-04 | 11 | 218 | 3 | PS50801 | |
| Domain | STAS | 2.42e-04 | 11 | 218 | 3 | PF01740 | |
| Domain | - | 2.42e-04 | 11 | 218 | 3 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.42e-04 | 11 | 218 | 3 | PF00916 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.19e-04 | 12 | 218 | 3 | IPR013041 | |
| Domain | - | 3.19e-04 | 12 | 218 | 3 | 1.50.10.20 | |
| Domain | Catenin_binding_dom | 3.41e-04 | 29 | 218 | 4 | IPR027397 | |
| Domain | - | 3.41e-04 | 29 | 218 | 4 | 4.10.900.10 | |
| Domain | CADHERIN_1 | 3.64e-04 | 113 | 218 | 7 | PS00232 | |
| Domain | Cadherin | 3.64e-04 | 113 | 218 | 7 | PF00028 | |
| Domain | - | 3.84e-04 | 114 | 218 | 7 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 3.84e-04 | 114 | 218 | 7 | PS50268 | |
| Domain | P-loop_NTPase | ADCY10 MYH7 LRRK2 CHD1 DNAH14 LONP1 RAB33A NOD1 RAB30 SEPTIN14 RAD54B KIF14 DLG1 DNAH8 DYNC2H1 DDX60 ZNFX1 MSH2 RAB41 RHEBL1 MYH15 ATP5F1A | 3.97e-04 | 848 | 218 | 22 | IPR027417 |
| Domain | CA | 4.04e-04 | 115 | 218 | 7 | SM00112 | |
| Domain | Cadherin-like | 4.26e-04 | 116 | 218 | 7 | IPR015919 | |
| Domain | IG | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PTGFRN PXDN LRFN5 MYBPHL MPZ SIGLEC14 HHLA2 HMCN1 ROBO2 | 4.48e-04 | 421 | 218 | 14 | SM00409 |
| Domain | Ig_sub | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PTGFRN PXDN LRFN5 MYBPHL MPZ SIGLEC14 HHLA2 HMCN1 ROBO2 | 4.48e-04 | 421 | 218 | 14 | IPR003599 |
| Domain | Cadherin | 4.73e-04 | 118 | 218 | 7 | IPR002126 | |
| Domain | - | 5.02e-04 | 32 | 218 | 4 | 3.40.1110.10 | |
| Domain | - | 5.02e-04 | 32 | 218 | 4 | 2.70.150.10 | |
| Domain | P_typ_ATPase_c | 5.19e-04 | 14 | 218 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.19e-04 | 14 | 218 | 3 | IPR032631 | |
| Domain | MT | 5.19e-04 | 14 | 218 | 3 | PF12777 | |
| Domain | AAA_8 | 5.19e-04 | 14 | 218 | 3 | PF12780 | |
| Domain | PhoLip_ATPase_C | 5.19e-04 | 14 | 218 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.19e-04 | 14 | 218 | 3 | PF16209 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-04 | 14 | 218 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-04 | 14 | 218 | 3 | IPR024743 | |
| Domain | TIL_dom | 5.19e-04 | 14 | 218 | 3 | IPR002919 | |
| Domain | P-type_ATPase_IV | 5.19e-04 | 14 | 218 | 3 | IPR006539 | |
| Domain | Ig_V-set | 5.65e-04 | 199 | 218 | 9 | IPR013106 | |
| Domain | Adaptin_N | 6.43e-04 | 15 | 218 | 3 | PF01602 | |
| Domain | DHC_fam | 6.43e-04 | 15 | 218 | 3 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.43e-04 | 15 | 218 | 3 | IPR002553 | |
| Domain | Dynein_heavy | 6.43e-04 | 15 | 218 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.43e-04 | 15 | 218 | 3 | IPR004273 | |
| Domain | ATPase_P-typ_cyto_domN | 7.12e-04 | 35 | 218 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 7.94e-04 | 36 | 218 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 7.94e-04 | 36 | 218 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 7.94e-04 | 36 | 218 | 4 | PS00154 | |
| Domain | cAMP_dep_PK_reg_su | 8.01e-04 | 4 | 218 | 2 | IPR012198 | |
| Domain | - | 8.01e-04 | 4 | 218 | 2 | 1.20.91.20 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.82e-04 | 37 | 218 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.82e-04 | 37 | 218 | 4 | PF00122 | |
| Domain | - | 9.02e-04 | 64 | 218 | 5 | 3.40.50.1000 | |
| Domain | C345C | 9.45e-04 | 17 | 218 | 3 | SM00643 | |
| Domain | PROTEIN_KINASE_TYR | 9.65e-04 | 97 | 218 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.65e-04 | 97 | 218 | 6 | IPR008266 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.12e-03 | 18 | 218 | 3 | IPR008930 | |
| Domain | - | ADCY10 LRRK2 CHD1 DNAH14 LONP1 RAB33A NOD1 RAB30 SEPTIN14 RAD54B DLG1 DNAH8 DYNC2H1 DDX60 ZNFX1 MSH2 RAB41 RHEBL1 ATP5F1A | 1.23e-03 | 746 | 218 | 19 | 3.40.50.300 |
| Domain | NTR | 1.32e-03 | 19 | 218 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 1.32e-03 | 19 | 218 | 3 | IPR018933 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.33e-03 | 5 | 218 | 2 | IPR001840 | |
| Domain | GAE | 1.33e-03 | 5 | 218 | 2 | PS50180 | |
| Domain | Anaphylatoxin_comp_syst | 1.33e-03 | 5 | 218 | 2 | IPR018081 | |
| Domain | Cadherin_CS | 1.76e-03 | 109 | 218 | 6 | IPR020894 | |
| Domain | IG_LIKE | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PTGFRN PXDN LRFN5 MYBPHL MPZ SIGLEC14 HHLA2 HMCN1 ROBO2 | 1.95e-03 | 491 | 218 | 14 | PS50835 |
| Domain | - | 1.97e-03 | 6 | 218 | 2 | 2.60.40.1230 | |
| Domain | Gasdermin | 1.97e-03 | 6 | 218 | 2 | PF04598 | |
| Domain | Na_trans_cytopl | 1.97e-03 | 6 | 218 | 2 | IPR024583 | |
| Domain | Na_trans_cytopl | 1.97e-03 | 6 | 218 | 2 | PF11933 | |
| Domain | RIIa | 1.97e-03 | 6 | 218 | 2 | SM00394 | |
| Domain | Clathrin_g-adaptin_app | 1.97e-03 | 6 | 218 | 2 | IPR008153 | |
| Domain | HAD-like_dom | 2.32e-03 | 79 | 218 | 5 | IPR023214 | |
| Domain | NTR | 2.34e-03 | 23 | 218 | 3 | PS50189 | |
| Domain | Netrin_domain | 2.34e-03 | 23 | 218 | 3 | IPR001134 | |
| Domain | Growth_fac_rcpt_ | 2.41e-03 | 156 | 218 | 7 | IPR009030 | |
| Domain | Ig-like_dom | PRTG FSTL5 OBSCN SIGLEC5 NCAM2 PTGFRN PXDN LRFN5 MYBPHL MPZ SIGLEC14 HHLA2 HMCN1 ROBO2 | 2.43e-03 | 503 | 218 | 14 | IPR007110 |
| Domain | ANATO | 2.74e-03 | 7 | 218 | 2 | SM00104 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SRM PTGFRN NUP205 ESYT2 PXDN AP1G1 XPO6 EIF2B4 NCAPD2 MMS19 TARBP1 RABGGTB DNMT1 MIA3 IPO7 DSC2 DSG2 HECTD3 DYNC2H1 RTN4 POLR1C MSH2 SACM1L CSE1L PRKAR2A | 2.93e-09 | 942 | 225 | 25 | 31073040 |
| Pubmed | KRT72 MYH7 CENPF ANKRD30B ATP10B COQ3 ADCY6 NUP205 PXDN AP2B1 UMODL1 VPS13A NCAPD2 XRN1 PKHD1 CC2D2A DLG1 USP1 CAMSAP2 DNAH8 ARHGAP21 EVL TAF1B DBNL APOB OGDH TENM1 MYH15 ATP5F1A XRCC6 GABPA | 5.00e-09 | 1442 | 225 | 31 | 35575683 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | CKAP5 PXDN NCAPD2 XRN1 MMS19 DNMT1 IPO7 DDX60 ZNFX1 MSH2 EGFR XRCC6 | 9.40e-09 | 202 | 225 | 12 | 33005030 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CKAP5 SRM CHD1 NUP205 LONP1 AP2B1 AP1G1 WASHC5 EIF2B4 NCAPD2 XRN1 ANKRD28 MMS19 DNMT1 IPO7 FN1 ARHGAP23 TAF1B NOB1 DBNL THUMPD3 POLR1C ADNP2 MSH2 USP16 CSE1L SFXN3 ATP5F1A XRCC6 | 1.75e-08 | 1353 | 225 | 29 | 29467282 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | KRT72 ACY1 ITGAV CPNE6 PXDN C3 C5 C7 FN1 DSC2 FOLH1 SLC26A2 APOB NIBAN2 APOH GGT2P LIFR HMCN1 LRP2 PRKAR2A PRKAR2B LTA4H ATP5F1A CDH15 UEVLD | 3.57e-08 | 1070 | 225 | 25 | 23533145 |
| Pubmed | TDRD15 LRRK2 DMXL1 EIF2B4 VPS13A XRN1 ANKRD28 DLG1 FAM135A ARHGAP21 DNMT1 STON1 FN1 DSC2 DSG2 APOB CASP12 EGFR PCCA PCDH7 ATP5F1A | 4.27e-08 | 777 | 225 | 21 | 35844135 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 CENPF TRPC1 CKAP5 CHD1 NUP205 LONP1 AP1G1 SUPT5H NCAPD2 KIF14 CC2D2A DNMT1 IPO8 IPO7 DSG2 DYNC2H1 RTN4 DBNL THUMPD3 APOB MSH2 OGDH SACM1L CSE1L SFXN3 PRKAR2A ATP5F1A XRCC6 | 5.35e-08 | 1425 | 225 | 29 | 30948266 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | GINM1 COQ3 PTGFRN TMCO4 XPO6 DLG1 MMS19 ATP13A3 FAM135A TARBP1 ARHGAP21 IPO8 DSG2 NOB1 NIBAN2 TBL1XR1 SACM1L EGFR ASB1 UEVLD | 5.71e-08 | 719 | 225 | 20 | 35337019 |
| Pubmed | CKAP5 ESYT2 SUPT5H NCAPD2 ANKRD28 MMS19 DNMT1 MIA3 DSG2 POLR1C MSH2 CSE1L PRKAR2A RCOR3 XRCC6 | 6.19e-08 | 399 | 225 | 15 | 37536630 | |
| Pubmed | CENPF CKAP5 CHD1 NUP205 LONP1 AP2B1 SUPT5H NCAPD2 XRN1 KIF14 ANKRD28 DNMT1 IPO7 FN1 MSH2 CSE1L PREP LTA4H XRCC6 | 6.20e-08 | 653 | 225 | 19 | 22586326 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TRAF3 CKAP5 CHD1 NUP205 ESYT2 AP2B1 SUPT5H EIF2B4 XRN1 ANKRD28 DLG1 C3 IPO8 IPO7 DSG2 RTN4 MSH2 DUSP19 PTPN5 CSE1L PREP SFXN3 FBXO21 | 1.08e-07 | 974 | 225 | 23 | 28675297 |
| Pubmed | KRT72 CKAP5 PHYHIP NCAM2 LONP1 CPNE6 AP2B1 AP1G1 WASHC5 XRN1 SYT1 DLG1 CAMSAP2 ARHGAP21 EVL FN1 ARHGAP23 RTN4 DBNL ARHGEF12 ZNFX1 OGDH SACM1L CSE1L SFXN3 PRKAR2A PRKAR2B ATP5F1A | 2.06e-07 | 1431 | 225 | 28 | 37142655 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ADCY6 ESYT2 RAB33A DLG1 ATP13A3 FAM135A ARHGAP21 MPZ DSC2 DSG2 SLC26A2 APOB NIBAN2 ATP10D EGFR SLC15A1 PCDH7 | 2.17e-07 | 569 | 225 | 17 | 30639242 |
| Pubmed | ADCY6 AP1G1 WASHC5 SUPT5H RAD54B XRN1 ANKRD28 DLG1 ARHGAP21 DNMT1 RC3H2 MIA3 ARHGAP23 HECTD3 RTN4 GPAM ZNFX1 SACM1L | 2.88e-07 | 650 | 225 | 18 | 38777146 | |
| Pubmed | PRTG PKD1L1 LRRK2 OBSCN CHD1 ITGAV DNAH14 DMXL1 PXDN WASHC5 RAD54B VPS13A NCAPD2 KIF14 ANKRD28 MMS19 MAP3K15 ARHGAP23 DSG2 RTN4 NIBAN2 AZIN1 TMEM168 TENM1 EXO1 | 3.90e-07 | 1215 | 225 | 25 | 15146197 | |
| Pubmed | SRM CHD1 DMXL1 ESYT2 EIF2B4 VPS13A ANKRD28 DLG1 FAM135A DNMT1 MIA3 IPO8 IPO7 DSC2 DSG2 HECTD3 DYNC2H1 RTN4 POLR1C NIBAN2 OGDH USP16 LIFR EGFR PRKAR2A PRKAR2B PCDH7 XRCC6 | 4.45e-07 | 1487 | 225 | 28 | 33957083 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PKD1L1 CKAP5 GGA3 NUP205 ESYT2 LONP1 WASHC5 XRN1 KIF14 ANKRD28 CAMSAP2 ARHGAP21 MIA3 IPO8 DSG2 NOB1 DBNL POLR1C LRP2 PCCA | 8.49e-07 | 853 | 225 | 20 | 28718761 |
| Pubmed | CKAP5 ESYT2 LONP1 AP2B1 AP1G1 SUPT5H EIF2B4 NCAPD2 ANKRD28 MMS19 IPO7 RTN4 TBL1XR1 CSE1L PRKAR2B ATP5F1A | 8.96e-07 | 560 | 225 | 16 | 35241646 | |
| Pubmed | CKAP5 ESYT2 NCAPD2 XRN1 DLG1 FAM135A ARHGAP21 IPO7 DSC2 DSG2 RTN4 ARHGEF12 NIBAN2 CSE1L EGFR PCDH7 ATP5F1A XRCC6 | 9.84e-07 | 708 | 225 | 18 | 39231216 | |
| Pubmed | 1.06e-06 | 4 | 225 | 3 | 32211850 | ||
| Pubmed | CKAP5 ESYT2 LONP1 WASHC5 SCN1A XRN1 SYT1 ANKRD28 DLG1 CAMSAP2 EVL MIA3 RTN4 DBNL ZNFX1 OGDH SACM1L CSE1L SFXN3 TENM1 PRKAR2A PRKAR2B PCCA | 1.61e-06 | 1139 | 225 | 23 | 36417873 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CENPF TOPAZ1 OBSCN CKAP5 SLC28A3 DNAH14 NUP205 TMCO4 VPS13A PKHD1 GFRAL FN1 GPAM PCARE GSDMC LRP2 LTA4H XRCC6 | 1.70e-06 | 736 | 225 | 18 | 29676528 |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 1.89e-06 | 57 | 225 | 6 | 23788249 | |
| Pubmed | TRAF3 PTGFRN NUP205 ESYT2 LONP1 PXDN AP2B1 EIF2B4 NCAPD2 KIF14 ANKRD28 MMS19 ATP13A3 IPO8 IPO7 DDX60 RTN4 NOB1 POLR1C MSH2 OGDH SACM1L LIFR CSE1L ATP5F1A XRCC6 | 2.56e-06 | 1440 | 225 | 26 | 30833792 | |
| Pubmed | 2.77e-06 | 179 | 225 | 9 | 19074885 | ||
| Pubmed | 5.27e-06 | 6 | 225 | 3 | 11087667 | ||
| Pubmed | ESYT2 LONP1 WASHC5 SUPT5H VPS13A KIF14 ANKRD28 DLG1 TRIM36 USP1 DNMT1 MIA3 IPO7 MSH2 DUSP19 NIBAN2 PTPN5 CSE1L EGFR PCDH7 ATP5F1A | 5.34e-06 | 1049 | 225 | 21 | 27880917 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KRT72 MYH7 ESYT2 PXDN EIF2B4 NCAPD2 C3 MMS19 IPO8 IPO7 DBNL SACM1L EGFR SFXN3 FBXO21 ATP5F1A | 5.67e-06 | 647 | 225 | 16 | 26618866 |
| Pubmed | GGA3 WASHC5 KIF14 CAMSAP2 RC3H2 MIA3 THUMPD3 ARHGEF12 MSH2 RCOR3 | 6.18e-06 | 251 | 225 | 10 | 29778605 | |
| Pubmed | 9.17e-06 | 7 | 225 | 3 | 27695111 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HIVEP1 SRM NUP205 LONP1 AP2B1 ANKRD28 DLG1 MMS19 USP1 TARBP1 DNMT1 IPO7 DYNC2H1 TAF1B POLR1C MSH2 NIBAN2 OGDH USP16 CSE1L | 9.83e-06 | 1005 | 225 | 20 | 19615732 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 CKAP5 NUP205 ESYT2 AP1G1 WASHC5 SUPT5H NCAPD2 DLG1 DNMT1 IPO8 DSG2 RTN4 POLR1C NIBAN2 OGDH TBL1XR1 SACM1L SFXN3 PRKAR2A LTA4H PCCA ATP5F1A XRCC6 | 1.01e-05 | 1367 | 225 | 24 | 32687490 |
| Pubmed | Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy. | 1.14e-05 | 22 | 225 | 4 | 25642632 | |
| Pubmed | 1.15e-05 | 330 | 225 | 11 | 21044950 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SNF8 LRRK2 ACY1 ITGAV PKHD1 C5 FN1 DSC2 DYNC2H1 DBNL ARHGEF12 NIBAN2 EYS CSE1L LRP2 PRKAR2A ROBO2 LTA4H ATP5F1A UEVLD | 1.15e-05 | 1016 | 225 | 20 | 19056867 |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 1.33e-05 | 47 | 225 | 5 | 14760718 | |
| Pubmed | TRAF3 SRM ITGAV PXDN AP2B1 C3 MMS19 RABGGTB DNMT1 MIA3 IPO7 DSG2 RTN4 DBNL THUMPD3 APOB SACM1L EGFR PREP PRKAR2A HACL1 ATP5F1A XRCC6 | 1.34e-05 | 1297 | 225 | 23 | 33545068 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAOA OBSCN NCAM2 SLC30A4 DNAH14 TMCO4 ESYT2 PXDN EIF2B4 SEL1L3 DLG1 ENPP5 EVL MIA3 FOLH1 VPS54 OGDH TBL1XR1 EGFR SFXN3 KYAT3 RCOR3 FBXO21 PCCA CDH15 | 1.40e-05 | 1489 | 225 | 25 | 28611215 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.41e-05 | 219 | 225 | 9 | 31353912 | |
| Pubmed | Regional differences in mitral cell development in mouse olfactory bulb. | 1.46e-05 | 8 | 225 | 3 | 30864157 | |
| Pubmed | Molecular organization and function of the complement system. | 1.46e-05 | 8 | 225 | 3 | 3052276 | |
| Pubmed | Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. | 1.64e-05 | 24 | 225 | 4 | 28818950 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 2.16e-05 | 231 | 225 | 9 | 36597993 | |
| Pubmed | Physiological roles and regulation of mammalian sulfate transporters. | 2.18e-05 | 9 | 225 | 3 | 11581495 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.24e-05 | 87 | 225 | 6 | 17148452 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | NUP205 NCAPD2 IPO7 HECTD3 RTN4 NOB1 DBNL THUMPD3 POLR1C MSH2 OGDH CSE1L PRKAR2A ATP5F1A | 2.42e-05 | 571 | 225 | 14 | 37167062 |
| Pubmed | 2.65e-05 | 54 | 225 | 5 | 36237976 | ||
| Pubmed | 2.74e-05 | 183 | 225 | 8 | 23956138 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 3.09e-05 | 28 | 225 | 4 | 27002738 | |
| Pubmed | N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. | 3.10e-05 | 10 | 225 | 3 | 24647542 | |
| Pubmed | CKAP5 NCAM2 AP2B1 SUPT5H DLG1 ENPP5 TARBP1 ARHGAP21 DNMT1 KLHL4 FN1 FOLH1 POLR1C ADNP2 ZNFX1 VPS54 ANKRD6 USP16 TMEM168 LRP2 ATP5F1A XRCC6 | 3.52e-05 | 1285 | 225 | 22 | 35914814 | |
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 4.10e-05 | 30 | 225 | 4 | 15632069 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24799499 | ||
| Pubmed | HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. | 4.17e-05 | 2 | 225 | 2 | 29920190 | |
| Pubmed | C1q is elevated during chronic Staphylococcus epidermidis central nervous system catheter infection. | 4.17e-05 | 2 | 225 | 2 | 38881889 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 9727058 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18285671 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 16204645 | ||
| Pubmed | Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. | 4.17e-05 | 2 | 225 | 2 | 16273099 | |
| Pubmed | T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells. | 4.17e-05 | 2 | 225 | 2 | 34630413 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 20935204 | ||
| Pubmed | Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. | 4.17e-05 | 2 | 225 | 2 | 23197535 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 30709927 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24667943 | ||
| Pubmed | CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer. | 4.17e-05 | 2 | 225 | 2 | 33874956 | |
| Pubmed | Complement decay-accelerating factor inhibits inflammation-induced myopia development. | 4.17e-05 | 2 | 225 | 2 | 38795684 | |
| Pubmed | Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5. | 4.17e-05 | 2 | 225 | 2 | 15383587 | |
| Pubmed | Human exonuclease I interacts with the mismatch repair protein hMSH2. | 4.17e-05 | 2 | 225 | 2 | 9788596 | |
| Pubmed | Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer. | 4.17e-05 | 2 | 225 | 2 | 24349229 | |
| Pubmed | Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. | 4.17e-05 | 2 | 225 | 2 | 30115995 | |
| Pubmed | Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor. | 4.17e-05 | 2 | 225 | 2 | 10330424 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 9030594 | ||
| Pubmed | LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2-GSDMD Axis-Mediated Gut Inflammation. | 4.17e-05 | 2 | 225 | 2 | 38607004 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 26459514 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 36756120 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 38671389 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 25573852 | ||
| Pubmed | Alterations in plasma complement levels after human ischemic stroke. | 4.17e-05 | 2 | 225 | 2 | 16823297 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 23610439 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18987342 | ||
| Pubmed | Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice. | 4.17e-05 | 2 | 225 | 2 | 30714990 | |
| Pubmed | Control of effector CD8+ T cell function by the transcription factor Eomesodermin. | 4.17e-05 | 2 | 225 | 2 | 14605368 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 29025596 | ||
| Pubmed | Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells. | 4.17e-05 | 2 | 225 | 2 | 32991634 | |
| Pubmed | Differential localization of T-bet and Eomes in CD8 T cell memory populations. | 4.17e-05 | 2 | 225 | 2 | 23455505 | |
| Pubmed | Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. | 4.17e-05 | 2 | 225 | 2 | 28278205 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 25032686 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 30462520 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 11853539 | ||
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 4.17e-05 | 2 | 225 | 2 | 16054936 | |
| Pubmed | The role of the complement anaphylatoxins in the recruitment of eosinophils. | 4.17e-05 | 2 | 225 | 2 | 18039528 | |
| Pubmed | Identification of Exo1-Msh2 interaction motifs in DNA mismatch repair and new Msh2-binding partners. | 4.17e-05 | 2 | 225 | 2 | 30061603 | |
| Pubmed | Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. | 4.17e-05 | 2 | 225 | 2 | 29155219 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 17148666 | ||
| Pubmed | A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. | 4.17e-05 | 2 | 225 | 2 | 18678517 | |
| Pubmed | The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. | 4.17e-05 | 2 | 225 | 2 | 22261438 | |
| Pubmed | Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways. | 4.17e-05 | 2 | 225 | 2 | 20525715 | |
| Pubmed | Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. | 4.17e-05 | 2 | 225 | 2 | 35907404 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 9430697 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24823810 | ||
| Interaction | LRRC31 interactions | CKAP5 PXDN NCAPD2 XRN1 MMS19 DNMT1 IPO7 DDX60 ZNFX1 MSH2 EGFR XRCC6 | 2.40e-06 | 205 | 217 | 12 | int:LRRC31 |
| Interaction | RHOF interactions | ITGAV NUP205 ESYT2 LONP1 VPS13A NCAPD2 KIF14 DLG1 MMS19 ATP13A3 FAM135A ARHGAP21 IPO7 DSC2 DSG2 SLC26A2 NIBAN2 CSE1L EGFR SFXN3 PRKAR2A PCDH7 | 3.92e-06 | 673 | 217 | 22 | int:RHOF |
| Interaction | GJA1 interactions | MYH7 GGA3 ESYT2 VPS13A DLG1 C3 ATP13A3 FAM135A ARHGAP21 MIA3 DSC2 DSG2 APOB VPS54 NIBAN2 EGFR LRP2 ROBO2 PCDH7 ATP5F1A | 5.43e-06 | 583 | 217 | 20 | int:GJA1 |
| Interaction | TNFSF13B interactions | 5.72e-06 | 119 | 217 | 9 | int:TNFSF13B | |
| Interaction | BTBD8 interactions | 9.51e-06 | 46 | 217 | 6 | int:BTBD8 | |
| Interaction | ANKFY1 interactions | SLC30A4 ANKRD28 ATP13A3 FAM135A ARHGAP21 RC3H2 DSC2 ARHGAP23 DSG2 ARHGEF12 EGFR LTA4H | 1.02e-05 | 236 | 217 | 12 | int:ANKFY1 |
| Interaction | VASP interactions | XPO6 RAB30 ANKRD28 CAMSAP2 FAM135A ARHGAP21 EVL FN1 DSG2 ARHGEF12 PCARE EGFR XIRP2 | 1.93e-05 | 294 | 217 | 13 | int:VASP |
| Interaction | ARHGEF2 interactions | WASHC5 KIF14 ANKRD28 MMS19 TRIM36 CAMSAP2 ARHGAP21 EVL RTN4 DBNL EGFR ROS1 | 2.29e-05 | 256 | 217 | 12 | int:ARHGEF2 |
| Interaction | KCNA3 interactions | ADCY10 LRRK2 CKAP5 ESYT2 VPS13A NCAPD2 XRN1 PKHD1 DLG1 FAM135A ARHGAP21 IPO7 DSC2 DSG2 RTN4 ARHGEF12 MSH2 NIBAN2 CSE1L EGFR LRP2 PCDH7 ATP5F1A XRCC6 | 2.45e-05 | 871 | 217 | 24 | int:KCNA3 |
| Interaction | RAB5A interactions | HIVEP1 LRRK2 CKAP5 SLC30A4 DMXL1 GGA3 NUP205 ESYT2 AP1G1 KIF14 DLG1 ATP13A3 FAM135A RABGGTB MIA3 DSC2 DSG2 RTN4 NIBAN2 EGFR LRP2 | 2.70e-05 | 706 | 217 | 21 | int:RAB5A |
| Interaction | DYRK1A interactions | TRAF3 CENPF CKAP5 PHYHIP GGA3 AP2B1 XRN1 KIF14 CAMSAP2 FN1 DBNL VPS54 SFXN3 LPIN2 LRP2 PRKAR2A PRKAR2B XRCC6 | 3.18e-05 | 552 | 217 | 18 | int:DYRK1A |
| Interaction | LMBR1L interactions | SRM PTGFRN NUP205 ESYT2 PXDN AP1G1 XPO6 EIF2B4 NCAPD2 MMS19 TARBP1 RABGGTB DNMT1 MIA3 IPO7 DSC2 DSG2 HECTD3 DYNC2H1 RTN4 POLR1C MSH2 SACM1L CSE1L PRKAR2A | 3.28e-05 | 946 | 217 | 25 | int:LMBR1L |
| Interaction | GPR182 interactions | ACY1 NUP205 ESYT2 WASHC5 XPO6 EIF2B4 NCAPD2 SEL1L3 ANKRD28 MMS19 ATP13A3 TARBP1 IPO8 SACM1L CSE1L SFXN3 | 3.63e-05 | 455 | 217 | 16 | int:GPR182 |
| Interaction | RHOB interactions | EPHB2 ITGAV ADCY6 NUP205 ESYT2 LONP1 AP2B1 VPS13A KIF14 DLG1 ATP13A3 FAM135A ARHGAP21 DSC2 DSG2 SLC26A2 ARHGEF12 NIBAN2 CSE1L EGFR SFXN3 ROBO2 PCDH7 | 4.02e-05 | 840 | 217 | 23 | int:RHOB |
| Interaction | MOB3C interactions | CKAP5 ESYT2 SUPT5H NCAPD2 MMS19 DNMT1 MIA3 DSG2 POLR1C MSH2 CSE1L PRKAR2A RCOR3 XRCC6 | 4.31e-05 | 364 | 217 | 14 | int:MOB3C |
| Interaction | RHOJ interactions | ITGAV NUP205 ESYT2 LONP1 VPS13A KIF14 DLG1 MMS19 ATP13A3 FAM135A ARHGAP21 DSC2 DSG2 NIBAN2 CSE1L EGFR SFXN3 PRKAR2A PCDH7 | 5.86e-05 | 633 | 217 | 19 | int:RHOJ |
| Interaction | COMTD1 interactions | CKAP5 NUP205 XPO6 EIF2B4 NCAPD2 ANKRD28 MMS19 IPO8 IPO7 CSE1L | 6.46e-05 | 200 | 217 | 10 | int:COMTD1 |
| Interaction | STX4 interactions | CENPF ESYT2 VPS13A SYT1 DLG1 FAM135A MIA3 FN1 DSC2 DSG2 RTN4 NIBAN2 LIFR EGFR PCDH7 | 6.62e-05 | 428 | 217 | 15 | int:STX4 |
| Interaction | RND1 interactions | MYH7 ITGAV LONP1 KIF14 DLG1 FAM135A DSC2 DSG2 NIBAN2 EGFR PCDH7 | 7.68e-05 | 246 | 217 | 11 | int:RND1 |
| Interaction | RND2 interactions | ITGAV NUP205 ESYT2 LONP1 VPS13A KIF14 DLG1 MMS19 FAM135A IPO7 DSC2 DSG2 CSE1L EGFR PCDH7 | 9.01e-05 | 440 | 217 | 15 | int:RND2 |
| Interaction | KRT8 interactions | KRT72 NUP205 ESYT2 KIF14 ANKRD28 TRIM36 CAMSAP2 ARHGAP21 MIA3 IPO8 FN1 ARHGEF12 EGFR PCDH7 XRCC6 | 9.24e-05 | 441 | 217 | 15 | int:KRT8 |
| Interaction | FAM81A interactions | 9.86e-05 | 23 | 217 | 4 | int:FAM81A | |
| Interaction | AKAP4 interactions | 9.86e-05 | 9 | 217 | 3 | int:AKAP4 | |
| Interaction | DIRAS3 interactions | ESYT2 DLG1 FAM135A ARHGAP21 IPO8 IPO7 DSC2 DSG2 NIBAN2 EGFR PCDH7 | 1.34e-04 | 262 | 217 | 11 | int:DIRAS3 |
| Interaction | RAB4A interactions | ACY1 SLC30A4 DMXL1 GGA3 ESYT2 AP2B1 VPS13A ATP13A3 FAM135A MIA3 DSG2 RTN4 VPS54 EGFR LRP2 | 1.37e-04 | 457 | 217 | 15 | int:RAB4A |
| Cytoband | 5p13-p12 | 7.15e-05 | 3 | 225 | 2 | 5p13-p12 | |
| Cytoband | 9q33-q34 | 1.43e-04 | 4 | 225 | 2 | 9q33-q34 | |
| GeneFamily | Fibronectin type III domain containing | EPHB2 PRTG OBSCN NCAM2 LRFN5 MYBPHL TRIM36 FN1 LIFR ROBO2 ROS1 | 1.09e-07 | 160 | 152 | 11 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.91e-06 | 161 | 152 | 9 | 593 | |
| GeneFamily | ATPase phospholipid transporting | 2.46e-04 | 15 | 152 | 3 | 1210 | |
| GeneFamily | Exportins | 1.43e-03 | 7 | 152 | 2 | 547 | |
| GeneFamily | Desmosomal cadherins | 1.43e-03 | 7 | 152 | 2 | 1188 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.43e-03 | 9 | 152 | 2 | 1234 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.43e-03 | 9 | 152 | 2 | 1203 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.57e-03 | 163 | 152 | 6 | 590 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 3.02e-03 | 10 | 152 | 2 | 53 | |
| GeneFamily | Complement system|Sushi domain containing | 3.39e-03 | 36 | 152 | 3 | 492 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ESYT2 VPS13A ANKRD28 DLG1 ARHGAP21 SLC26A2 ARHGEF12 GPAM MSH2 VPS54 TBL1XR1 SACM1L LIFR | 1.19e-06 | 289 | 221 | 13 | M2196 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | EPHB2 CENPF TNFRSF11A ITGAV NUP205 DBF4 RAD54B NCAPD2 KIF14 ANKRD28 USP1 DNMT1 DSG2 EXO1 MUC5AC | 1.85e-06 | 402 | 221 | 15 | MM454 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CENPF CKAP5 ESYT2 DBF4 XRN1 KIF14 DLG1 ATP13A3 TRIM36 USP1 DNMT1 RC3H2 FN1 DSG2 DYNC2H1 TBL1XR1 USP16 CSE1L EGFR | 1.28e-05 | 721 | 221 | 19 | M10237 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 HIVEP1 CENPF TRPC1 CKAP5 CHD1 XPO6 DBF4 VPS13A KIF14 ANKRD28 DLG1 ATP13A3 CAMSAP2 IPO7 MSH2 AZIN1 TDRD7 CSE1L EGFR PCCA | 1.30e-05 | 856 | 221 | 21 | M4500 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | CENPF CKAP5 NUP205 AP2B1 DBF4 EIF2B4 NCAPD2 KIF14 MMS19 RABGGTB DNMT1 IPO7 POLR1C MSH2 CSE1L LTA4H XRCC6 | 1.91e-05 | 612 | 221 | 17 | M4772 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | EPHB2 MAOA ATP8A2 TRPC1 CPNE6 AP2B1 SCN1A SYT1 TRIM36 TARBP1 IPO7 FN1 DSC2 RTN4 COX11 MSH2 AZIN1 CSE1L PREP TENM1 PRKAR2B FBXO21 PCCA PCDH7 ATP5F1A CDH18 | 2.09e-05 | 1248 | 221 | 26 | M17728 |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN | 5.15e-05 | 199 | 221 | 9 | M9434 | |
| Coexpression | GSE27786_LSK_VS_CD4_TCELL_UP | 5.35e-05 | 200 | 221 | 9 | M4745 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_UP | 5.35e-05 | 200 | 221 | 9 | M8473 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 6.48e-05 | 205 | 221 | 9 | M3961 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 PKHD1 ZAN FOLH1 APOB HMCN1 XIRP2 TENM1 LRP2 MYH15 ROS1 | 1.77e-10 | 184 | 224 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 PKHD1 ZAN FOLH1 APOB HMCN1 XIRP2 TENM1 LRP2 MYH15 ROS1 | 1.77e-10 | 184 | 224 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 PKHD1 ZAN FOLH1 APOB HMCN1 XIRP2 TENM1 LRP2 MYH15 ROS1 | 1.77e-10 | 184 | 224 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ATP10B DNAH14 SCN1A SEL1L3 ANKRD28 C3 FAM135A NIBAN2 LTA4H ROS1 | 2.90e-09 | 186 | 224 | 11 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.66e-08 | 194 | 224 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.54e-08 | 197 | 224 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-07 | 159 | 224 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-07 | 167 | 224 | 9 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.11e-07 | 184 | 224 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.15e-07 | 189 | 224 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 190 | 224 | 9 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | WDR64 TOPAZ1 ANKRD30B UMODL1 PKHD1 DNAH8 ZAN SLC6A16 SLC26A5 | 6.14e-07 | 193 | 224 | 9 | 315840bc48899f3a36d57b19197509de19716e3d |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.14e-07 | 193 | 224 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-07 | 194 | 224 | 9 | fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-07 | 194 | 224 | 9 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-07 | 194 | 224 | 9 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.69e-07 | 195 | 224 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.98e-07 | 196 | 224 | 9 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.29e-07 | 197 | 224 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 145 | 224 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.60e-07 | 198 | 224 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.60e-07 | 198 | 224 | 9 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.26e-07 | 200 | 224 | 9 | 6461d25fd8fb52921b188f083fbe808535d3130b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.55e-07 | 150 | 224 | 8 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 162 | 224 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-06 | 171 | 224 | 8 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 172 | 224 | 8 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 174 | 224 | 8 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 174 | 224 | 8 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 175 | 224 | 8 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 175 | 224 | 8 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-06 | 176 | 224 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-06 | 176 | 224 | 8 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-06 | 176 | 224 | 8 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-06 | 177 | 224 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.58e-06 | 179 | 224 | 8 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 180 | 224 | 8 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-06 | 181 | 224 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.22e-06 | 183 | 224 | 8 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-06 | 184 | 224 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.35e-06 | 189 | 224 | 8 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-06 | 190 | 224 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.56e-06 | 190 | 224 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 191 | 224 | 8 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.78e-06 | 191 | 224 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 191 | 224 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 191 | 224 | 8 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.78e-06 | 191 | 224 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 191 | 224 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 191 | 224 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.78e-06 | 191 | 224 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 191 | 224 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 6.00e-06 | 192 | 224 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.24e-06 | 193 | 224 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 6.24e-06 | 193 | 224 | 8 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.48e-06 | 194 | 224 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.48e-06 | 194 | 224 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-06 | 194 | 224 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-06 | 194 | 224 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.48e-06 | 194 | 224 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.48e-06 | 194 | 224 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.48e-06 | 194 | 224 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.48e-06 | 194 | 224 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.73e-06 | 195 | 224 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.73e-06 | 195 | 224 | 8 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.98e-06 | 196 | 224 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.98e-06 | 196 | 224 | 8 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.98e-06 | 196 | 224 | 8 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-06 | 197 | 224 | 8 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-06 | 197 | 224 | 8 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.25e-06 | 197 | 224 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.25e-06 | 197 | 224 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.25e-06 | 197 | 224 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.80e-06 | 199 | 224 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-06 | 199 | 224 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.80e-06 | 199 | 224 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.80e-06 | 199 | 224 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.80e-06 | 199 | 224 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 199 | 224 | 8 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.09e-06 | 200 | 224 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.09e-06 | 200 | 224 | 8 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 200 | 224 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 148 | 224 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 148 | 224 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 149 | 224 | 7 | 7726957b1de638c3bfc659381d15eab626bb179b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Sema3c_(Entorhinal_cortex)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 58 | 224 | 5 | c4d5faa29ee606e5682865624f4b5cffda8fb650 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Sema3c_(Entorhinal_cortex)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 58 | 224 | 5 | 69c0632da1f82800951c11d456a36be9c5abb999 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 157 | 224 | 7 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 160 | 224 | 7 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 160 | 224 | 7 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 162 | 224 | 7 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 163 | 224 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | C_02|World / shred on cell type and cluster | 2.06e-05 | 165 | 224 | 7 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| Disease | Colorectal Carcinoma | FSTL5 OBSCN CHD1 VPS13A PKHD1 CAMSAP2 DNAH8 EVL FN1 FOLH1 RTN4 APOB MSH2 LIFR CSE1L EGFR TENM1 EXO1 LRP2 | 1.34e-06 | 702 | 218 | 19 | C0009402 |
| Disease | Cleft palate, cleft lip | TDRD15 TMCO4 RAD54B PKHD1 DLG1 FGF10 MPZ GFRAL STON1 TAF1B ROBO2 | 8.09e-06 | 279 | 218 | 11 | EFO_0003959, HP_0000175 |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_marker_for) | 1.36e-05 | 7 | 218 | 3 | DOID:0050431 (is_marker_for) | |
| Disease | mean reticulocyte volume | CHD1 NUP205 LONP1 NOD1 AP2B1 VPS13A CC2D2A ENPP5 USP1 ARHGAP21 ANGPT1 STON1 TBL1XR1 AZIN1 LPIN2 RCOR3 PCOLCE2 CDH15 | 3.04e-05 | 799 | 218 | 18 | EFO_0010701 |
| Disease | C5a anaphylatoxin measurement | 1.62e-04 | 3 | 218 | 2 | EFO_0020208 | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 1.62e-04 | 3 | 218 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 1.69e-04 | 15 | 218 | 3 | EFO_0007804, GO_0036273 | |
| Disease | brain connectivity measurement | FES SYT1 TRIM36 MPZ ANGPT1 STON1 RTN4 ROBO2 PCCA PCDH7 CDH18 | 2.08e-04 | 400 | 218 | 11 | EFO_0005210 |
| Disease | diabetes mellitus (is_marker_for) | 2.37e-04 | 41 | 218 | 4 | DOID:9351 (is_marker_for) | |
| Disease | serum metabolite measurement | TDRD15 PKD1L1 UGT3A1 CKAP5 SLC28A3 ACY1 USP1 RABGGTB DNMT1 ANGPT1 FOLH1 GPAM APOB ATP10D SACM1L SLC17A1 KYAT3 PCOLCE2 | 2.49e-04 | 945 | 218 | 18 | EFO_0005653 |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.51e-04 | 17 | 218 | 3 | EFO_0022232 | |
| Disease | factor VIII deficiency (is_marker_for) | 3.23e-04 | 4 | 218 | 2 | DOID:12134 (is_marker_for) | |
| Disease | bronchiolo-alveolar adenocarcinoma (is_marker_for) | 3.23e-04 | 4 | 218 | 2 | DOID:4926 (is_marker_for) | |
| Disease | uncharacterized protein C10orf35 measurement | 3.23e-04 | 4 | 218 | 2 | EFO_0802189 | |
| Disease | Cardiomyopathy | 4.03e-04 | 47 | 218 | 4 | cv:C0878544 | |
| Disease | intermediate density lipoprotein measurement | 4.75e-04 | 87 | 218 | 5 | EFO_0008595 | |
| Disease | response to radiation | 5.01e-04 | 88 | 218 | 5 | GO_0009314 | |
| Disease | 2-hydroxysebacate measurement | 5.35e-04 | 5 | 218 | 2 | EFO_0800571 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 6.45e-04 | 93 | 218 | 5 | DOID:3525 (biomarker_via_orthology) | |
| Disease | phosphatidylinositol measurement | 7.10e-04 | 95 | 218 | 5 | EFO_0010230 | |
| Disease | body fat percentage, coronary artery disease | 7.18e-04 | 24 | 218 | 3 | EFO_0001645, EFO_0007800 | |
| Disease | Adenocarcinoma of large intestine | 7.45e-04 | 96 | 218 | 5 | C1319315 | |
| Disease | urate measurement, bone density | WDR64 FSTL5 DNAH14 FSIP2 KIF14 DNAH8 FAM135A TAF1B SLC26A5 OGDH EYS PRKAR2A PRKAR2B | 7.53e-04 | 619 | 218 | 13 | EFO_0003923, EFO_0004531 |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 7.99e-04 | 6 | 218 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | pneumocystosis (biomarker_via_orthology) | 7.99e-04 | 6 | 218 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | paracentral lobule volume measurement | 8.11e-04 | 25 | 218 | 3 | EFO_0010317 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 8.56e-04 | 99 | 218 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 9.79e-04 | 102 | 218 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | total lipids in IDL | 1.02e-03 | 60 | 218 | 4 | EFO_0022161 | |
| Disease | leprosy | 1.02e-03 | 103 | 218 | 5 | EFO_0001054 | |
| Disease | free cholesterol in IDL measurement | 1.09e-03 | 61 | 218 | 4 | EFO_0022181 | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 1.11e-03 | 7 | 218 | 2 | cv:C0349788 | |
| Disease | regulator of G-protein signaling 8 measurement | 1.11e-03 | 7 | 218 | 2 | EFO_0801997 | |
| Disease | acute myocardial infarction (is_marker_for) | 1.11e-03 | 7 | 218 | 2 | DOID:9408 (is_marker_for) | |
| Disease | lumbar disc degeneration | 1.14e-03 | 28 | 218 | 3 | EFO_0004994 | |
| Disease | stimulant use measurement | 1.14e-03 | 28 | 218 | 3 | EFO_0600076 | |
| Disease | Ciliopathies | 1.37e-03 | 110 | 218 | 5 | C4277690 | |
| Disease | Primary familial dilated cardiomyopathy | 1.39e-03 | 30 | 218 | 3 | cv:C0340427 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.46e-03 | 66 | 218 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 1.48e-03 | 8 | 218 | 2 | EFO_0801373 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.48e-03 | 8 | 218 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.48e-03 | 8 | 218 | 2 | DOID:4608 (is_marker_for) | |
| Disease | susceptibility to chronic sinus infection measurement | 1.63e-03 | 68 | 218 | 4 | EFO_0008419 | |
| Disease | joint hypermobility measurement | 1.84e-03 | 33 | 218 | 3 | EFO_0007905 | |
| Disease | Complement deficiency disease | 1.84e-03 | 33 | 218 | 3 | C0272242 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0801463 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.89e-03 | 9 | 218 | 2 | C0085548 | |
| Disease | Osteitis Deformans | 1.89e-03 | 9 | 218 | 2 | C0029401 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0800439 | |
| Disease | RNA-binding protein 24 measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0802030 | |
| Disease | glutamate carboxypeptidase 2 measurement | 1.89e-03 | 9 | 218 | 2 | EFO_0020408 | |
| Disease | white matter hyperintensity measurement | 1.92e-03 | 302 | 218 | 8 | EFO_0005665 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.01e-03 | 34 | 218 | 3 | EFO_0009926 | |
| Disease | Primary dilated cardiomyopathy | 2.01e-03 | 34 | 218 | 3 | cv:C0007193 | |
| Disease | Malignant neoplasm of prostate | EPHB2 CENPF CHD1 ENPP5 FGF10 DNMT1 FOLH1 TBL1XR1 LIFR EGFR LRP2 ROBO2 | 2.23e-03 | 616 | 218 | 12 | C0376358 |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 2.35e-03 | 10 | 218 | 2 | EFO_0801544 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.35e-03 | 10 | 218 | 2 | EFO_0801535 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.35e-03 | 10 | 218 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | angina pectoris | 2.41e-03 | 125 | 218 | 5 | EFO_0003913 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 2.57e-03 | 37 | 218 | 3 | EFO_0022281 | |
| Disease | interleukin 10 measurement | 2.70e-03 | 78 | 218 | 4 | EFO_0004750 | |
| Disease | aortic measurement | 2.74e-03 | 251 | 218 | 7 | EFO_0020865 | |
| Disease | X-18913 measurement | 2.86e-03 | 11 | 218 | 2 | EFO_0800795 | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 2.86e-03 | 11 | 218 | 2 | EFO_0800279 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.96e-03 | 80 | 218 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | cholesterol in very small VLDL measurement | 3.21e-03 | 40 | 218 | 3 | EFO_0022231 | |
| Disease | Nerve Degeneration | 3.38e-03 | 83 | 218 | 4 | C0027746 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.42e-03 | 12 | 218 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 3.42e-03 | 12 | 218 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.42e-03 | 12 | 218 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | oncostatin-M measurement | 3.42e-03 | 12 | 218 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 3.42e-03 | 12 | 218 | 2 | EFO_0020833 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 3.42e-03 | 12 | 218 | 2 | EFO_0008284 | |
| Disease | Sudden infant death syndrome | 3.42e-03 | 12 | 218 | 2 | C0038644 | |
| Disease | distal myopathy (implicated_via_orthology) | 3.42e-03 | 12 | 218 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | epilepsy | 3.45e-03 | 41 | 218 | 3 | EFO_0000474 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 3.57e-03 | 137 | 218 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Glioma | 4.00e-03 | 87 | 218 | 4 | C0017638 | |
| Disease | osteitis deformans | 4.02e-03 | 13 | 218 | 2 | EFO_0004261 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 4.02e-03 | 13 | 218 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | rhinitis (biomarker_via_orthology) | 4.02e-03 | 13 | 218 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.02e-03 | 13 | 218 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | TDRD15 AP1G1 EIF2B4 ELAPOR1 MYBPHL USP1 FN1 TBX21 APOB APOH MYLIP PCOLCE2 | 4.03e-03 | 663 | 218 | 12 | EFO_0004615 |
| Disease | asthma | TRAF3 HIVEP1 NEK10 CDHR3 ATP10B TNFRSF11A ITGAV TBX21 NIBAN2 TBL1XR1 PREP MUC5AC XRCC6 | 4.07e-03 | 751 | 218 | 13 | MONDO_0004979 |
| Disease | Familial dilated cardiomyopathy | 4.21e-03 | 44 | 218 | 3 | C0340427 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.41e-03 | 206 | 218 | 6 | C0152013 | |
| Disease | monocyte count | TRAF3 HIVEP1 SIGLEC5 PTGFRN GGT5 XPO6 SYT1 C3 DNMT1 MPZ ANGPT1 IPO8 FN1 ARHGAP23 ARHGEF12 SIGLEC14 OGDH EGFR GSDMD | 4.42e-03 | 1320 | 218 | 19 | EFO_0005091 |
| Disease | ureteral obstruction (biomarker_via_orthology) | 4.49e-03 | 45 | 218 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.49e-03 | 45 | 218 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 4.49e-03 | 45 | 218 | 3 | EFO_0022236 | |
| Disease | Abnormality of refraction | EPHB2 PKD1L1 RGMA NOD1 LRFN5 ANGPT1 ATP6V1E2 PCDHA13 TDRD7 PTPN5 PCCA PCDH7 | 4.53e-03 | 673 | 218 | 12 | HP_0000539 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKRVYEVISVQVQDV | 251 | Q5DID0 | |
| VEAVKIITGSDLQVY | 61 | Q9NWW7 | |
| AVTAYQNTDITQLKI | 431 | O95936 | |
| GVKVYTENVDKRQII | 251 | A0FGR8 | |
| IYLKQVTATVLINGT | 246 | Q14032 | |
| ATVVYQGERVKIQEK | 271 | P02749 | |
| ATLLSYGAVIEVQNK | 156 | Q9BXX2 | |
| TKVNYVVQEAIVVIR | 401 | P63010 | |
| IYISKIVVEFLQSNS | 506 | P26358 | |
| VTETKFNNILVRVYV | 81 | P22760 | |
| QVSQIKYAAKVGVNI | 116 | O14977 | |
| IQVTTDLYQVLAAKG | 1126 | O43306 | |
| IYTIINSILNEVQVG | 426 | Q9H7F0 | |
| LVDVKGQTALYVAVV | 106 | Q9Y576 | |
| TTINKTQLSYALGIV | 251 | Q9NZJ6 | |
| ALKNAGQAVTIVAQY | 531 | Q12959 | |
| YVVTEAVELINNTVL | 156 | Q9BYG8 | |
| NVYVVTEVLQTQKEV | 156 | P57764 | |
| EVTNKVGGIYTVIQT | 36 | P54840 | |
| VLLTSLNGKQEVYTA | 86 | Q8NB90 | |
| VLINQGASILVKDYI | 601 | O15084 | |
| VVEKVVLVSLQSGYL | 116 | P01024 | |
| KENLQGLVTRQTYII | 216 | Q15389 | |
| DRTVLGILVSYQIKV | 321 | P10523 | |
| TKTIREGVLAIINYV | 246 | A6NFU0 | |
| VIKNRNTTYIVIGAV | 686 | Q96PN6 | |
| LGYSVVIKENLTAQE | 131 | Q6UXS9 | |
| IDVQSIIDAVYQTGI | 1386 | Q6DHV5 | |
| SNQYQVVDDIVSKLV | 321 | Q9UBU7 | |
| QVNIYRLVTKGSVEE | 906 | O14646 | |
| ISKYVGEVFNIVSQQ | 791 | Q9Y485 | |
| EAETIKNGIYNITVL | 536 | Q02487 | |
| ISLLVTLEVVKYTQA | 376 | Q9NTI2 | |
| ISLYVSIELVKLGQV | 381 | O94823 | |
| ISLYVSIEIVKLGQI | 386 | Q9P241 | |
| SIEIVKLGQIYFIQS | 391 | Q9P241 | |
| YVAIGQKRSTVAQLV | 246 | P25705 | |
| VAAYKGQTENVVQLI | 16 | Q9Y2G4 | |
| VRKVQNYTVNILGET | 131 | Q6IQ32 | |
| GAQIYELVAQTVSEK | 1106 | Q9NZN5 | |
| EQSTGQATKYSVLLV | 426 | O95741 | |
| VKTVVHGLVDFIQNY | 381 | Q9HBD1 | |
| TKVIQEIARVENSYG | 161 | Q8TAI7 | |
| TTEEQLLAVQGVRKY | 291 | Q9P2K3 | |
| EKVVLVSNYTQTLNI | 661 | Q9Y620 | |
| YVQIRIFKIIVIGDS | 31 | Q14088 | |
| EIEQYASNKVITVLV | 106 | Q15771 | |
| IAVVVYDITNINSFK | 106 | Q5JT25 | |
| QVAYDGVEITVQKVI | 416 | P54829 | |
| TEIAIAAQQLGIKYI | 41 | Q9UJ83 | |
| NVQQVIYATGALAKA | 416 | P12883 | |
| VINSAGYKILTSVDQ | 116 | Q96TA1 | |
| GLTYKVLTLVSQIDV | 181 | Q92621 | |
| VYDNGTLDILITTVK | 336 | Q96NI6 | |
| TIEKVVINGQEVKYA | 61 | P09960 | |
| SKNVGNAILYETVLT | 281 | O43747 | |
| KVVSIYGSSIDVELQ | 546 | O43747 | |
| VNVSERLVQYVKGKT | 91 | P21397 | |
| QNGTYTVKIVAISED | 461 | Q14126 | |
| VTAALYGVVNVKKVL | 371 | O94952 | |
| QIVQQAVKYVGQLAV | 1376 | Q15058 | |
| QLAAYINRTVGQTVK | 46 | Q9H079 | |
| QDIGKNIYTIREVVT | 21 | Q9ULX3 | |
| TTVRVDNGQKYTLLI | 1961 | Q5T1H1 | |
| VDTQVAYILSLGVVK | 91 | Q9H7X0 | |
| AADVKSGNYTVLQVV | 36 | Q96T76 | |
| TVQLSVQVISYQGIE | 91 | Q06546 | |
| ISKQQVVLNITYESG | 56 | Q9NU53 | |
| TNDVAKIYSINVTNV | 566 | Q6UXG2 | |
| GEVKRQIYVAAFTVQ | 726 | Q04609 | |
| VVYVAPTKALVNQVA | 811 | Q8IY21 | |
| AGKIVNTVLQELYVT | 2771 | Q5CZC0 | |
| VQKIVNSVYGKVLDQ | 5021 | Q5CZC0 | |
| NTVTVQGLKAGAIYV | 491 | P29323 | |
| TLESVVFGINYTKQL | 206 | Q9P2D6 | |
| QENSKLTSVVGTILY | 681 | Q6ZWH5 | |
| FAVGVQQVLLKVLYQ | 296 | O95373 | |
| VIGNSLILVIIKYEN | 41 | Q9H2C5 | |
| YEISKQRLSIVIGVV | 871 | O60245 | |
| KYGVHVKQVTNVFIT | 56 | Q9UJA9 | |
| DQQVVINYSIVKGLK | 56 | Q9UI08 | |
| LSIQNGIIVTKATRY | 3451 | Q96JB1 | |
| CYVGTAIQVITNKVV | 121 | Q9UM44 | |
| NQITDVGARYVTKIL | 766 | Q9Y239 | |
| NVYLTVTKESGNSIV | 236 | Q8WY64 | |
| VAEIQTKGFQTILAI | 641 | Q5S007 | |
| TVVVDTALYIAKQNS | 2356 | Q5S007 | |
| INVSGYVAQEKLAIA | 656 | P36776 | |
| LSRVINSYKTIIEGQ | 286 | Q9NZ52 | |
| IETVTYDGIQRKTVV | 581 | P98164 | |
| VVIKASGEVFLNQIY | 501 | P98088 | |
| VSIINIYKEGNLAIQ | 336 | Q9UKZ9 | |
| EVVQIGTSIFYKAIE | 176 | Q9H4Q4 | |
| VLTVSLNYGEVQTKI | 41 | Q6IE36 | |
| SIQFLGTVYKVNILT | 626 | P05165 | |
| STYVNEVVVLIVVGI | 191 | Q8NGG8 | |
| RYVQEKIVLAAQAIS | 306 | Q9UI10 | |
| STVGVVALNNKLYAI | 561 | Q9C0H6 | |
| LVSINDVKGLVRVQY | 706 | Q8N475 | |
| IAGTSQKYFNIDVLV | 1436 | Q96RW7 | |
| VYKVTVLENAFNGTL | 246 | Q9Y5I0 | |
| VAGNVYIVKISASNE | 886 | Q2VWP7 | |
| KGVVTEAEVKVYIQQ | 6556 | Q5VST9 | |
| TLYDSINVIDVNKVV | 106 | P53611 | |
| LYAKNENTGVVVVKT | 81 | Q8NHR9 | |
| TVKGIDASDYQTVQI | 426 | P48147 | |
| VLQKYAELLVSQGVV | 536 | Q02218 | |
| VLKQNDYVVETSLVG | 2156 | Q8NCM8 | |
| IVLYQKGQASVKVID | 236 | Q9NR20 | |
| TIQEVAGYVLIALNT | 81 | P00533 | |
| IREVGTVLSQVYSKV | 4221 | P04114 | |
| VTVYNVHGDQVFKLI | 1391 | Q14008 | |
| AIVAKYLQQVRESVI | 966 | Q9P2K1 | |
| IQTSGSNYKTLEVLV | 136 | Q96P09 | |
| YIVLQSSVNGLIQEV | 2496 | P49454 | |
| ETVGVLAVNIYIEKN | 196 | Q9UBN1 | |
| KAAYIDILGTVLQVQ | 276 | Q6UXV0 | |
| QSLVDSYVAIVNKTV | 36 | Q6PK57 | |
| EYTVSLVAIKGNQES | 1061 | P02751 | |
| LAAGNKYTVIIQVQD | 421 | Q6ZTQ4 | |
| QNKTTLTYVAAVAVG | 91 | Q9Y6N1 | |
| YSVVRGEQIQLKGTV | 831 | P01031 | |
| GQLISDQVAEIVSKY | 211 | P06756 | |
| KSYQLLVVENTVEVA | 246 | P10643 | |
| ESKQTVLIVGTLLYA | 506 | Q92819 | |
| IYNVTTGKVEVINAR | 96 | P36269 | |
| ALEKVIYTATQQLGL | 1386 | Q0VDD8 | |
| QTYIRKVGDTVNLLI | 61 | A2RUH7 | |
| EVYENAKIGTVVGTV | 391 | Q13634 | |
| ILVTKDNQTRSVGQY | 186 | P13861 | |
| VIGTKVYNDGEQIIA | 291 | P31323 | |
| VEIGVVAVKAINSNY | 116 | O15520 | |
| FKTIVSLSIVYTIGQ | 81 | P46059 | |
| HFDSQVIIYGKQVII | 291 | Q9NTJ5 | |
| VQIKSDKQQLGSVIY | 66 | P55291 | |
| AIVKEIVNISSGYVE | 576 | P43246 | |
| NYTALAKVQIEGSVV | 751 | Q8TDX9 | |
| DAVIQALAQKGLYVT | 101 | Q08AD1 | |
| VYQKTNAVSEIKRVG | 161 | Q9UJU6 | |
| QIDSNKEILVTVGAY | 121 | Q6YP21 | |
| LTIYNSTTGKAEVIN | 91 | P36268 | |
| NVTIKGVENSSYLVA | 481 | P42702 | |
| YVVTKENSVGLIIAI | 826 | P42702 | |
| LQYTVSKLQVLNGTV | 271 | A6NGG8 | |
| TQGVEYNKIVSLLVS | 261 | Q8NGT5 | |
| TYAVGIQQVLLKILD | 296 | O15397 | |
| LVRESQGKQEYVLSV | 481 | P07332 | |
| GDNVLVNTYSGVVKI | 776 | Q6ZN16 | |
| LVKLYALTSQVINGE | 51 | Q5VVY1 | |
| ATVQGNYEDTVQVKV | 126 | Q9P2B2 | |
| TISFRIYKGVIQAIQ | 1051 | Q9NQC3 | |
| EQIQKVQVVVTVLDY | 351 | P21579 | |
| YVVNTSKQTELLGEL | 396 | Q9NQ86 | |
| QIVVTTSIGQDLKSY | 366 | Q68CR1 | |
| GLQQLVVAKISDVYN | 321 | Q9GZN6 | |
| YSVTAAKQGIFQVVI | 216 | Q9BWM7 | |
| SNVQLKLTVVETVGY | 101 | Q6ZU15 | |
| VAQEALKYTVLSGIV | 336 | Q5TGY1 | |
| SLVGIQVKGYVQAIL | 146 | B5MCY1 | |
| VLVVKDRVYQVTEQQ | 1201 | Q5JRA6 | |
| LQGVNVIDAVKNYSI | 346 | Q86VH5 | |
| TVKYDVQAVAIIVVV | 351 | Q53T94 | |
| FSVVYSTVAVLQNVK | 241 | P58743 | |
| IKVGNEYVTRGQTIE | 416 | Q9Y2K3 | |
| TVGKFIQYGILTVAE | 646 | Q9HCL2 | |
| AQGIVATAQFEIYVK | 146 | Q14916 | |
| LSIVGTVLSDIIQKY | 1601 | Q14524 | |
| YELQVQKSVTVQEGL | 21 | O15389 | |
| RIQQVTTNGEIYIIA | 1451 | Q9UKZ4 | |
| VAVQTAVKQSDGEYL | 86 | Q92561 | |
| TLVDNTIGLLAVVYV | 3171 | P08F94 | |
| VKVRDTYLDTQVVGQ | 986 | O00267 | |
| KVLVYNNTSIVQDEI | 91 | O15160 | |
| VLYSVFSQIEKTNIA | 246 | P40879 | |
| VNGVQQYISIRSEII | 541 | Q9HAS3 | |
| ELSNTNEVVIRYVGK | 471 | Q8NHU6 | |
| EIQAKYIGTTIVVRQ | 271 | Q96B86 | |
| AYLNKAGIVQAIITE | 156 | Q9UQ84 | |
| SIIQKGLQYVEAEVS | 51 | Q9BZK7 | |
| SIEKNITVNYNGTLI | 291 | P35498 | |
| TVVLQLAEKNGYVTV | 181 | Q96H20 | |
| QEVTKAVVVDLGTGY | 66 | Q9Y615 | |
| VNLTKLEGGVAYNVI | 251 | Q03154 | |
| GGVNQYVVQEVLSIK | 21 | Q15021 | |
| SKFVVYQIIVIQTGS | 91 | Q7Z614 | |
| VGTYNVVVVIVLTKL | 626 | P48995 | |
| ETVYVIKSVTQEDIQ | 1191 | A4UGR9 | |
| DIVISVGIYNLVQKA | 266 | P12956 | |
| VVAKNYGVSIRLNQV | 401 | Q6NUS8 | |
| VFVAQTVLENGTYIK | 536 | Q13114 | |
| LVTTGQEVKYDLLVS | 301 | P55060 | |
| SGELVSYVRKVLQII | 616 | Q12768 | |
| VGISLVNNYTKQEVA | 2531 | Q96RL7 | |
| KQEVAYIGITSSDVV | 2541 | Q96RL7 | |
| LGQVVDYVRKQASIT | 131 | Q9Y5T5 | |
| QTQEATVVLEIYQKL | 101 | O15394 | |
| KSVVVVQGAYVELQA | 531 | Q9Y6Q2 | |
| VQVVLQQTYGSTLKV | 1236 | Q9UBZ9 | |
| YVIQTLEETTKQNVL | 771 | Q0IIM8 | |
| YSLQKSVLGVITIVN | 476 | P50443 | |
| SIQKGVYVTVIIEVG | 166 | Q8N7C7 | |
| ESVIGKTYSQVIALI | 126 | Q9P227 | |
| NVAGEVKTQEVTLRY | 321 | Q92626 | |
| VVQATRVVETALIKY | 521 | P63133 | |
| GIIINETSAVVYAQL | 786 | Q8IZH2 | |
| SAVLVNLKKGVTYEI | 696 | Q9HCK4 | |
| NVRVVVVYKTGENST | 1726 | P08922 | |
| SKTYGNVLVLDGVIQ | 56 | P19623 | |
| DQYIAVQGAELIKTV | 561 | Q9H0V1 | |
| TYVGLKIVQALLTNE | 626 | Q9P2E3 | |
| KDSIAVEVYSVQNIL | 1781 | Q9P2E3 | |
| GKIYFVISVESLAQV | 71 | Q9BV44 | |
| LLYQVQASKQEITAV | 1246 | Q8N9V7 | |
| DLVQSVGVLIAAYII | 281 | O14863 | |
| LQYIITNVLKAQTSG | 326 | Q8IX04 | |
| SIYSVFKVAAIQQIL | 631 | Q6PGP7 | |
| QQKKTEGYTIIGVEQ | 1531 | Q13395 | |
| IGVEQTAKSLDLTQY | 1541 | Q13395 | |
| VVERLVKVTLYGSQI | 586 | Q96QU8 | |
| SENVYVTQKETVAQL | 466 | Q2TAA8 | |
| SVIGKTYSQVIALIQ | 131 | Q5T5U3 | |
| KLEQVYNIAVTSSVG | 321 | P15822 | |
| YELQVQKSVTVQEGL | 21 | Q08ET2 | |
| AVTAYQNAEITQLKI | 301 | Q9UL17 | |
| ISGFENKISYVVQSL | 726 | O94782 | |
| VLIVEGQQYAVVGTV | 731 | Q9P1Q0 | |
| NFKGDIIVVYVSQTS | 541 | Q9Y6Q6 | |
| IQVIYVEEKQVVLTA | 871 | B1ANS9 | |
| VEVYSGNQRIKVSNT | 181 | Q96A05 | |
| SSIYSIVNIKIGVQV | 2031 | Q9Y493 | |
| YVQDLSSDLQVGVIK | 56 | Q8WTR2 | |
| NLGSVKQYVESIDVS | 236 | Q5T447 | |
| TLYQTKIQELQVTAG | 316 | Q14CN4 | |
| QLAGQVIVTVKELYK | 6 | Q92539 | |
| VIVTVKELYKGINQA | 11 | Q92539 | |
| VGKTSQVTLYVFEKV | 136 | P25189 |